ClinicalTrials.gg
RecruitingNCT06983834Updated May 21, 2025

Mindfulness Psychoeducation for Bipolar Disorder Caregivers' Mindfulness, Burden, Quality of Life and Resilience

An interventional study of Psychoeducation in Bipolar Disorder, sponsored by Pamukkale University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-21.

Sponsored by Pamukkale University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 45 studies in Bipolar Disorder with a site in Turkey — 10 open to participants now, 11 under way, none of them phase 3. Bipolar Disorder · Turkey.

Planned enrollment
16th of 26
46 · median 50
Started
2025
with 10 others
No phase
18 of 45
4 open now
Primary completion
2025-09
later than 1 of 10 live
Registered
26th of 45
by date
Lead sponsor
2 of 45
Pamukkale University

Among the 45 studies in Bipolar Disorder with a site in Turkey, this one is the 16th largest by planned enrollment of the 26 interventional ones that give a count, is one of 11 that started in 2025, is one of 18 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 26th registered.

Bipolar Disorder

1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.

Browse Bipolar Disorder studies →

Open to participants now

10 of the 45 studies in Bipolar Disorder with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Bipolar Disorder with a site in Turkey, or all of them as a file.
02

Study summary

This study was designed to determine the effect of mindfulness-based psychoeducation applied to primary caregivers of individuals diagnosed with bipolar disorder on their mindfulness, caregiver burden, quality of life, and psychological resilience.

Read the detailed description

Bipolar disorder is a chronic mental illness characterized by alternating episodes of opposing mood states (mania/hypomania and depression) and euthymic periods. Providing continuous care to individuals diagnosed with bipolar disorder can be highly challenging. Considering factors such as medication management, hospital follow-ups, patient behavior during episodes, and their attitudes toward themselves and others, being a primary caregiver is a demanding responsibility. Caregivers may face challenges such as constant caregiving burden, social isolation, burnout, neglecting self-care, and ignoring their own need for help. However, due to their perceived obligation to prioritize the patient, they may find themselves without adequate support.

Psychiatric nurses should approach not only the chronically mentally ill patient but also their caregivers, who are integral parts of the patient's environment, from a holistic perspective. The home environment of the patient, and particularly the attitude of the family and primary caregiver, plays a significant role in the prevention of relapses. From this holistic point of view, psychoeducation programs are expected to increase caregivers' psychological resilience, quality of life, and mindfulness levels, while reducing their caregiving burden. Such outcomes are anticipated to not only benefit the caregiver and the patient but also strengthen the broader society, as they may contribute to the reduction of relapse rates. Consequently, this could positively impact the national economy by decreasing healthcare utilization. Protecting caregivers may also lead to a reduced need for healthcare services directed toward them.

Psychoeducation is one of the core roles of psychiatric nurses. The recognition and expansion of mindfulness-based psychoeducation practices in the field are expected to provide significant support to both patients and their families.

03

Conditions studied

  • Bipolar Disorder

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older,
  • At least a primary school graduate,
  • Able to hear, understand spoken language, and communicate,
  • Has been a primary caregiver for at least 6 months and is participating voluntarily.

Exclusion criteria

Exclusion Criteria:

  • Currently participating in another psychoeducation group,
  • Diagnosed with any mental disorder.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Caregivers of Bipolar Disorder Patients (Experimental)

    Mindfulness-based psychoeducation will be applied to the experimental group.There will be pre-test and post-tests.

    Behavioral: Psychoeducation

  • No intervention
    Caregivers of Bipolar Disorder Patients (Control)

    Only pre-test and post-tests will be applied without any intervention.

Interventions

  • BehavioralPsychoeducation

    Mindfulness Based Psychoeducation

06

What researchers measure

Primary outcomes

  1. The Descriptive Characteristics Form

    The Descriptive Characteristics Form consists of 16 questions related to individuals' sociodemographic information and personal characteristics (Age, Gender, Marital Status, Educational Status, Employment Status, Income Level, Caregiving Support, Duration of Being the Primary Caregiver, Smoking and Alcohol Use, Hobby Status, Social Support Information). It is a data collection tool developed based on a literature review.

    Time frame: 6 months

Secondary outcomes

  1. Zarit Burden Interview

    The scale was developed by Zarit, Reever, and Bach-Peterson to measure caregiver burden.It is a scale that can be completed either by the caregivers themselves or through interviews conducted by the researcher. The scale uses a Likert-type rating system ranging from 0 to 4 (never, rarely, sometimes, quite frequently, nearly always). Scores on the scale range from 0 to 88. The items primarily focus on social and emotional aspects, and a higher total score indicates a greater level of burden or distress experienced by the caregiver.

    Time frame: 6 months

  2. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36, Short Form-36 Health Survey)

    The SF-36 Survey was developed by Ware and Sherbourne (1992) to assess quality of life.This scale is used to assess physical and mental health in individuals over the age of 14, whether they have various health conditions or are healthy. The SF-36 is a generic quality of life scale and provides a comprehensive evaluation. The scale consists of 36 items, which include: physical functioning (10 items), role limitations due to physical health problems (2 items), social functioning (2 items), role limitations due to emotional problems (3 items), mental health (5 items), vitality (4 items), bodily pain (2 items), general health perceptions (5 items), and perceived change in health status (1 item). Each item is evaluated individually and scored on a scale from 0 to 100.

    Time frame: 6 months

  3. Resilience Scale for Adults

    The scale was developed by Friborg et al. (2003) to measure psychological resilience in adults. The scale consists of 33 items and 6 subscales: self-perception, perception of the future, structured style, social competence, family cohesion, and social resources. It is a 5-point Likert-type scale. The response options are scored as follows: 1 - Strongly Disagree, 2 - Disagree, 3 - Neutral, 4 - Agree, and 5 - Strongly Agree.

    Time frame: 6 months

  4. Mindful Attention Awareness Scale

    The scale was developed by Brown and Ryan (2003) to measure the level of mindfulness and consists of 15 items.In the scale, each item is scored based on how frequently the individual experiences that specific situation. It is a 6-point Likert-type scale with the following response options: "Almost never: 6," "Very rarely: 5," "Rarely: 4," "Sometimes: 3," "Often: 2," and "Almost always: 1." The total score on the scale ranges from a minimum of 15 to a maximum of 90. Based on the total score, individuals scoring between 66 and 90 are considered to have a high level of mindfulness, scores between 41 and 65 indicate a moderate level, and scores of 40 or below reflect a low level of mindfulness.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Sep 2025, 4 months after the start.

Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 4 months is below that.

Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2025
First posted
May 21, 2025
StartActual
May 1, 2025
Primary completionEst.
Sep 15, 2025
CompletionEst.
Aug 15, 2026
Last update
May 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06983834
Responsible party
Azime Korkmaz (PhD student, Pamukkale University) — Principal investigator
First posted
May 21, 2025
Start date
May 1, 2025
Primary completion
Sep 15, 2025 (estimated)
Completion
Aug 15, 2026 (estimated)
Last update
May 21, 2025

Study contacts

Azime KORKMAZ, PhDStudent
Contact
korkmazime@gmail.com
905064053614
Gülay TAŞDEMİR, AssocProfDr.
Contact
gyigitoglu@pau.edu.tr
905386418674
Gülay TAŞDEMİR, AssocProfDr
study director · https://akbis.pau.edu.tr/personel/226

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion